![Jørgen Buus Lassen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jørgen Buus Lassen
Directeur/Membre du Conseil chez
Effector A/S
Profil
Jørgen Buus Lassen is the founder of NTG Nordic Transport Group A, which was founded in 1989.
He held the position of Scientific Director from 1989 to 2008.
Dr. Buus Lassen's current jobs include Director positions at Effector A, Evalua A, and membership at Collegium Internationale Neuro-Psychopharmacologicum.
He formerly held Chairman positions at Zealand Pharma A, NsGene A (1999-2008), Gudme Raaschou Health Care (2003-2010), and Director positions at Nicox SA (1989-2009), Pharmexa A, Gudme Raaschou Invest A, Sophion Bioscience A, Egetis Therapeutics AB, Scanbur A, and Spago Nanomedical AB. Dr. Buus Lassen earned a doctorate degree from the University of Copenhagen.
Postes actifs de Jørgen Buus Lassen
| Sociétés | Poste | Début |
|---|---|---|
Effector A/S
 Effector A/S Miscellaneous Commercial ServicesCommercial Services Provides health communication and public relation services | Directeur/Membre du Conseil | 11/08/2010 |
Evalua A/S | Directeur/Membre du Conseil | 08/09/2011 |
Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | 08/09/2011 |
Anciens postes connus de Jørgen Buus Lassen
| Sociétés | Poste | Fin |
|---|---|---|
| NICOX SA | Directeur/Membre du Conseil | 21/06/2013 |
Gudme Raaschou Invest A/S
 Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management. | Directeur/Membre du Conseil | 28/03/2011 |
Gudme Raaschou Health Care | Président | 01/01/2010 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Directeur/Membre du Conseil | 16/06/2009 |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Président | 01/06/2008 |
Formation de Jørgen Buus Lassen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Gudme Raaschou Invest A/S
Gudme Raaschou Invest A/S Gudme Raaschou Invest A/S (GRI) is an investment management firm based in Copenhagen, Denmark. GRI is a wholly-owned subsidiary of Gudme Raaschou Asset Management Holding A/S, which is a wholly-owned subsidiary of Gudme Raaschou Bank A/S, and ultimately of Copenhagen-based Gudme Raaschou Holding A/S. The firm administers and distributes the Gudme Raaschou Health Care unit trust, as well as the Gudme Raaschou unit trust, which is composed of several compartments: Nordic Alpha, European Bonds, High Yield and US High Yield. Both unit trusts are managed by their affiliate, Gudme Raaschou Asset Management. | |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments and supplies automated patch clamping | Health Technology |
Collegium Internationale Neuro-Psychopharmacologicum | |
Effector A/S
Effector A/S Miscellaneous Commercial ServicesCommercial Services Provides health communication and public relation services | Commercial Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Gudme Raaschou Health Care | |
Scanbur A/S
 Scanbur A/S Medical SpecialtiesHealth Technology Designs, manufactures and sells biomedical research animal vivarium equipment | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Evalua A/S |
